![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Neural Analytics Obtains CE Mark for Robotic Ultrasound System
Neural Analytics Obtains CE Mark for Robotic Ultrasound System
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
June 21, 2018
Medical Robotics Company Neural Analytics secured CE Mark certification for its NeuralBot robotic ultrasound system.
The device can regulate its position and orientation with professional guidance, and can help physicians diagnose brain disorders, possibly without the need for more invasive testing.
It can be used with the Lucid M1 Transcranial Doppler Ultrasound System, a device that provides a platform for analyzing brain waveforms, to observe a patient’s blood flow characteristics, which can be used to diagnose multiple neurological disorders.
Upcoming Events
-
21Oct